597 related articles for article (PubMed ID: 18240313)
1. GFAP promoter elements required for region-specific and astrocyte-specific expression.
Lee Y; Messing A; Su M; Brenner M
Glia; 2008 Apr; 56(5):481-93. PubMed ID: 18240313
[TBL] [Abstract][Full Text] [Related]
2. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.
Lee Y; Su M; Messing A; Brenner M
Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522
[TBL] [Abstract][Full Text] [Related]
3. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions.
Sousa Vde O; Romão L; Neto VM; Gomes FC
Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546
[TBL] [Abstract][Full Text] [Related]
4. GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue.
Nolte C; Matyash M; Pivneva T; Schipke CG; Ohlemeyer C; Hanisch UK; Kirchhoff F; Kettenmann H
Glia; 2001 Jan; 33(1):72-86. PubMed ID: 11169793
[TBL] [Abstract][Full Text] [Related]
5. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M
J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain.
Giralt M; Carrasco J; Penkowa M; Morcillo MA; Santamaría J; Campbell IL; Hidalgo J
Exp Neurol; 2001 Apr; 168(2):334-46. PubMed ID: 11259121
[TBL] [Abstract][Full Text] [Related]
7. Normal and pathological expression of GFAP promoter elements in transgenic mice.
Galou M; Pournin S; Ensergueix D; Ridet JL; Tchélingérian JL; Lossouarn L; Privat A; Babinet C; Dupouey P
Glia; 1994 Dec; 12(4):281-93. PubMed ID: 7890332
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression.
Ye P; Popken GJ; Kemper A; McCarthy K; Popko B; D'Ercole AJ
J Neurosci Res; 2004 Nov; 78(4):472-84. PubMed ID: 15468174
[TBL] [Abstract][Full Text] [Related]
9. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of a glial fibrillary acidic protein-LacZ transgene in retinal astrocytes and Müller cells.
Verderber L; Johnson W; Mucke L; Sarthy V
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1137-43. PubMed ID: 7730023
[TBL] [Abstract][Full Text] [Related]
11. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes.
Johnson WB; Ruppe MD; Rockenstein EM; Price J; Sarthy VP; Verderber LC; Mucke L
Glia; 1995 Mar; 13(3):174-84. PubMed ID: 7782103
[TBL] [Abstract][Full Text] [Related]
12. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
Su W; Xing R; Guha A; Gutmann DH; Sherman LS
Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-I regulates glial fibrillary acidic protein gene expression in astrocytes differentiated from cortical precursor cells.
Cebolla B; Vallejo M
J Neurochem; 2006 May; 97(4):1057-70. PubMed ID: 16606365
[TBL] [Abstract][Full Text] [Related]
14. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury.
Mucke L; Oldstone MB; Morris JC; Nerenberg MI
New Biol; 1991 May; 3(5):465-74. PubMed ID: 1883812
[TBL] [Abstract][Full Text] [Related]
15. Isolation of cDNA clones encoding rat glial fibrillary acidic protein: expression in astrocytes and in Schwann cells.
Feinstein DL; Weinmaster GA; Milner RJ
J Neurosci Res; 1992 May; 32(1):1-14. PubMed ID: 1629938
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of mouse 3-phosphoglycerate dehydrogenase (Phgdh) gene promoter in developing brain.
Shimizu M; Furuya S; Shinoda Y; Mitoma J; Okamura T; Miyoshi I; Kasai N; Hirabayashi Y; Suzuki Y
J Neurosci Res; 2004 Jun; 76(5):623-32. PubMed ID: 15139021
[TBL] [Abstract][Full Text] [Related]
17. GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibit a reduced amount of intermediate filaments and an increased cell saturation density.
Pekny M; Eliasson C; Chien CL; Kindblom LG; Liem R; Hamberger A; Betsholtz C
Exp Cell Res; 1998 Mar; 239(2):332-43. PubMed ID: 9521851
[TBL] [Abstract][Full Text] [Related]
18. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
McKie EA; Graham DI; Brown SM
Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567
[TBL] [Abstract][Full Text] [Related]
19. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
[TBL] [Abstract][Full Text] [Related]
20. Transgenic analysis of GFAP promoter elements.
Yeo S; Bandyopadhyay S; Messing A; Brenner M
Glia; 2013 Sep; 61(9):1488-99. PubMed ID: 23832770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
